CT perfusion imaging in response assessment of pulmonary metastases undergoing stereotactic ablative radiotherapy

Journal of Medical Imaging and Radiation Oncology

Volumn 59, Issue 2, 2015, Pages 207-215

  Sawyer, Brooke ^a,b   Pun, Emma ^a   Samuel, Michael ^a,c   Tay, Huilee ^a   Kron, Tomas ^a   Bressel, Mathias ^a   Ball, David ^a   Siva, Shankar ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b Epworth Medical Imaging   (Australia)

^c Wide Bay Hospital and Health Service   (Australia)

Author keywords

CT perfusion; pulmonary metastases; RECIST; SABR; stereotactic radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SCINTISCANNING; CANCER SIZE; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED SCINTIGRAPHY; CORRELATION COEFFICIENT; FEMALE; HUMAN; IMAGING SOFTWARE; INTERVENTIONAL RADIOLOGIST; LUNG BLOOD FLOW; LUNG BLOOD VOLUME; LUNG METASTASIS; LUNG SCINTISCANNING; MALE; PERMEABILITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE; RADIATION RESPONSE; REPRODUCIBILITY; STEREOTACTIC ABLATIVE BODY RADIOTHERAPY; STEREOTACTIC TREATMENT; SURFACE PROPERTY; TREATMENT RESPONSE; TUMOR ABLATION; ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; LUNG NEOPLASMS; MIDDLE AGED; PROCEDURES; RADIOGRAPHY; RADIOSURGERY; SECONDARY; TREATMENT OUTCOME;

AGED; ANGIOGRAPHY; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; RADIOSURGERY; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84926522627     PISSN: 17549477     EISSN: 17549485     Source Type: Journal    
DOI: 10.1111/1754-9485.12272     Document Type: Article

References (26)

1. Mahesh M,. Dual-source CT and 320-slice MDCT and special applications: CT fluoroscopy and CT perfusion. In:, Brown B, Shaw R, (eds). MDCT Physics: The Basics: Technology, Image Quality and Radiation Dose. Lippincott Williams & Wilkins, Philadelphia, 2009; 157-163.
2. Ma S-H, Le H-B, Jia B-H, et al. Peripheral pulmonary nodules: relationship between multislice spiral CT perfusion imaging and tumour angiogenesis and VEGF expression. BMC Cancer 2008; 8: 186.
3. Yi CA, Lee KS, Kim EA, et al. Solitary pulmonary nodules: dynamic enhanced multidetector row CT study and comparison with vascular endothelial growth factor and microvessel density. Radiology 2004; 233: 191-199.
4. Tateishi U, Nishihara H, Tsukamoto E, Morikawa T, Tamaki N, Miyasaka K,. Lung tumors evaluated with FDG-PET and dynamic CT: the relationship between vascular density and glucose metabolism. J Comput Assist Tomogr 2002; 26: 185-190.
5. Jinzaki M, Tanimoto A, Mukai M, et al. Double phase helical CT of small renal parenchymal neoplasms: correlation with pathologic findings and tumor angiogenesis. J Comput Assist Tomogr 2000; 24: 835-842.
6. Ng CS, Wang X, Faria SC, Lin E, Charnsangavej C, Tannir NM,. Perfusion CT in patients with metastatic renal cell carcinoma treated with interferon. AJR Am J Roentgenol 2010; 194: 166-171.
7. Fraioli F, Anzidei M, Zaccagna F, et al. Whole-tumor perfusion CT in patients with advanced lung adenocarcinoma treated with conventional and antiangiogenetic chemotherapy: initial experience. Radiology 2011; 259: 2574-2582.
8. Fraioli F, Anzidei M, Serra G, et al. Whole-tumour CT-perfusion of unresectable lung cancer for the monitoring of anti-angiogenic chemotherapy effects. Br J Radiol 2013; 86: 20120174.
9. Ng Q-S, Goh V, Milner J, Padhani AR, Saunders MI, Hoskin PJ,. Acute tumour vascular effects following fractionated radiotherapy in human lung cancer: in vivo whole tumour assessment using volumetric perfusion computed tomography. Int J Radiat Oncol Biol Phys 2007; 67: 417-424.
10. Wang J, Wu N, Cham MD, Song Y,. Tumour response in patients with advanced non-small cell lung cancer: perfusion CT evaluation of chemotherapy and radiation therapy. AJR Am J Roentgenol 2009; 293: 1090-1096.
11. Park HJ, Griffin RJ, Hui S, Levitt SH, Song CW,. Radiation-induced vascular damage in tumors: implications of vascular damage in ablative hypofractionated radiotherapy (SBRT and SRS). Radiat Res 2012; 177: 311-327.
12. Aoki T, Nagata Y, Negoro Y, et al. Evaluation of lung injury after three-dimensional conformal stereotactic radiation therapy for solitary lung tumors: CT appearance. Radiology 2004; 230: 101-108.
13. Guckenberger M, Heilman K, Wulf J, Mueller G, Beckmann G, Flentje M,. Pulmonary injury and tumor response after stereotactic body radiotherapy (SBRT): results of a serial follow-up CT study. Radiother Oncol 2007; 85: 435-442.
14. Takeda A, Kunieda E, Takeda T, et al. Possible misinterpretation of demarcated solid patterns of radiation fibrosis on CT scans as tumor recurrence in patients receiving hypofractionated stereotactic radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys 2008; 70: 1057-1065.
15. Siva S, MacManus M, Ball D,. Stereotactic radiotherapy for pulmonary oligometastases: a systematic review. J Thorac Oncol 2010; 5: 1091-1099.
16. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000; 92: 205-216.
17. Siva S, Chesson B, Aarons Y, et al. Implementation of a lung radiosurgery program: technical considerations and quality assurance in an Australian institution. J Med Imaging Radiat Oncol 2012; 56: 354-361.
18. Siva S, Devereux T, Kron T, et al. Vacuum immobilisation reduces tumour excursion and minimises intrafraction error in a cohort study of stereotactic ablative body radiotherapy for pulmonary metastases. J Med Imaging Radiat Oncol. 2014; 58: 244-252.
19. Ketelsen D, Horger M, Buchgeister M, et al. Estimation of radiation exposure of 128-Slice 4D-perfusion CT for the assessment of tumor vascularity. Korean J Radiol 2010; 11: 547-552.
20. Lee SM, Lee HJ, Kim JI, et al. Adaptive 4D volume perfusion CT of lung cancer: effects of computerized motion correction and the range of volume coverage on measurement reproducibility. AJR Am J Roentgenol 2013; 200: W603-609.
21. Ng Q-S, Goh V, Fichte H, et al. Lung cancer perfusion at multi-detector row CT: reproducibility of whole tumour quantitative measurements. Radiology 2006; 239: 547-553.
22. Huang K, Senthi S, Palma DA, et al. High-risk CT features for detection of local recurrence after stereotactic ablative radiotherapy for lung cancer. Radiother Oncol 2013; 109: 51-57.
23. Henderson MA, Hoopes DJ, Fletcher JW, et al. A pilot trial of serial 18F-fluorodeoxyglucose positron emission tomography in patients with medically inoperable stage I non-small-cell lung cancer treated with hypofractionated stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 2010; 76: 789-795.
24. Petralia G, Bonello L, Viotti S, Preda L, D'Andrea G, Bellomi M,. CT perfusion in oncology: how to do it. Cancer Imaging 2010; 10: 8-19.
25. Garcia-Figueiras R, Goh VJ, Padhani AR, et al. CT perfusion in oncologic imaging: a useful tool? AJR Am J Roentgenol 2013; 200: 8-19.
26. Sauter AW, Merkle A, Schulze M, et al. Intraobserver and interobserver agreement of volume perfusion CT (VPCT) measurements in patients with lung lesions. Eur J Radiol 2012; 81: 2853-2859.